Vincent du Vigneaud

Vincent du Vigneaud
Maxdugan26 · CC BY-SA 4.0 · source
Name	Vincent du Vigneaud
Birth date	May 18, 1901
Birth place	Chicago, Illinois
Death date	December 11, 1978
Death place	White Plains, New York
Nationality	American
Fields	Biochemistry
Institutions	Cornell University, University of Illinois Urbana–Champaign, University of Pennsylvania, Massachusetts Institute of Technology, Rockefeller University
Alma mater	University of Illinois Urbana–Champaign, Northwestern University
Doctoral advisor	John Jacob Abel
Known for	Oxytocin synthesis, sulfur biochemistry, peptide hormones
Prizes	Nobel Prize in Chemistry

Vincent du Vigneaud was an American biochemist noted for chemical synthesis of peptide hormones and seminal work on sulfur-containing compounds. He elucidated structures and functions of biological peptides, developed methods in peptide chemistry, and received the Nobel Prize in Chemistry for his synthesis of oxytocin. His career connected laboratories and institutions across the United States and Europe and influenced research in endocrinology, neurochemistry, and pharmaceutical chemistry.

Early life and education

Du Vigneaud was born in Chicago and raised in Glen Ellyn, Illinois, entering Northwestern University for undergraduate studies and later earning a Ph.D. at the University of Illinois Urbana–Champaign under mentors connected to the lineage of Emil Fischer and John Jacob Abel. During postgraduate training he worked at laboratories associated with Cornell University and the Rockefeller Institute for Medical Research, interacting with contemporaries from Harvard University, Columbia University, and Massachusetts Institute of Technology. His early academic network included figures tied to Otto Folin, Einar Hammarsten, and researchers in peptide chemistry influenced by work at University of Leipzig and University of Zurich.

Scientific career and research

Du Vigneaud held faculty positions at institutions such as Cornell University, George Washington University, University of Illinois Urbana–Champaign, and Columbia University before a long tenure at the University of Illinois and Cornell Medical College. His research program investigated sulfur biochemistry, peptide hormones, and amino acid metabolism, building on foundations laid by scientists like Gilbert Newton Lewis, Frederick Gowland Hopkins, and Fritz Lipmann. He explored biochemical pathways related to cysteine and methionine, routing to studies by Hans Krebs and Arthur Harden, and engaged with analytical methods developed by Sune K. Bergström and Konrad Bloch. Collaborations and interactions connected him to laboratories at Johns Hopkins University, Yale University, University of Pennsylvania, and Rockefeller University, while his approaches in synthesis paralleled techniques used by Robert Robinson and Linus Pauling.

Du Vigneaud's laboratory advanced methods in peptide bond formation and disulfide bridge manipulation, influencing the work of contemporaries such as Dorothy Crowfoot Hodgkin, Max Perutz, and John Kendrew. He trained students who later joined faculties at Massachusetts Institute of Technology, Stanford University, University of California, Berkeley, and Princeton University. His studies on peptide hormones interfaced with clinical research at institutions like Mayo Clinic and Massachusetts General Hospital.

Nobel Prize and major discoveries

In 1955 du Vigneaud was awarded the Nobel Prize in Chemistry for the first synthesis of a polypeptide hormone, oxytocin, following biochemical characterization influenced by earlier isolated peptides from laboratories at University College London and Institut Pasteur. His synthesis confirmed the sequence and the disulfide bond arrangement, advancing knowledge that connected to work by Ernest Fourneau, Henry Hallett Dale, and Otto Loewi on chemical mediators. The oxytocin synthesis had implications for obstetrics and neuroendocrinology studies at St Bartholomew's Hospital and King's College London.

Beyond oxytocin, du Vigneaud made seminal contributions to sulfur metabolism, elucidating pathways involving homocysteine and methionine that resonated with metabolic research by Alexander Fleming-era scientists and postwar biochemical investigators at Carnegie Institution and Rockefeller Foundation-funded labs. His elucidation of peptide structure and methodology influenced synthetic strategies later used by researchers at Salk Institute and pharmaceutical companies like Merck and Pfizer.

Personal life and legacy

Du Vigneaud married and raised a family while maintaining an active laboratory; his personal correspondence and manuscripts later entered archives associated with Cornell University and the National Library of Medicine. He received honors from societies including the National Academy of Sciences and the American Chemical Society, and was awarded medals akin to those granted by the Royal Society and European academies. His pedagogical legacy continued through protégés who became faculty at Columbia University, Yale University, University of Chicago, and international centers such as Karolinska Institutet and Max Planck Society institutes. Institutions and lectureships at universities like Cornell University and University of Illinois Urbana–Champaign commemorate his impact on peptide chemistry, endocrinology, and sulfur biochemistry.

Selected publications and patents

- Du Vigneaud V., synthesis and characterization papers published in journals linked to American Chemical Society and Proceedings of the National Academy of Sciences; his work was cited alongside papers from Nature and Science. - Monographs and reviews appearing in collections associated with Cold Spring Harbor Laboratory and conference proceedings of the American Association for the Advancement of Science. - Patents filed on peptide synthesis techniques and hormone derivatives subsequently used by pharmaceutical departments at Eli Lilly and Company and GlaxoSmithKline.

Category:American biochemists Category:Nobel laureates in Chemistry Category:1901 births Category:1978 deaths